Ninety-Day Outcome Rates of a Prospective Cohort of Consecutive Patients With Mild Ischemic Stroke

被引:247
作者
Khatri, Pooja [1 ]
Conaway, Mark R. [2 ]
Johnston, Karen C. [2 ]
机构
[1] Univ Cincinnati, Dept Neurol, Cincinnati, OH 45267 USA
[2] Univ Virginia Hlth Syst, Charlottesville, VA USA
基金
美国国家卫生研究院;
关键词
cerebral infarct; prognosis; stroke care; TISSUE-PLASMINOGEN ACTIVATOR; ELIGIBILITY;
D O I
10.1161/STROKEAHA.110.593897
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Prior studies have shown that patients with mild ischemic stroke have substantial disability rates at hospital discharge. We sought to determine disability rates at 90 days among patients not treated with thrombolytic therapy and explore the role of early neurological worsening. Methods-We reviewed a prospective cohort of 136 consecutive patients with mild deficits (National Institutes of Health Stroke Scale score <= 5) presenting within 24 hours of onset and no baseline disability. Baseline MRIs were performed on all subjects. Five-day MRIs were performed on a prespecified subcohort. Results-Among 136 patients, 40 (29%; 95% CI, 22%-38%) had poor outcomes (modified Rankin Scale score 2-6) at 90 days. Early worsening (4-point National Institutes of Health Stroke Scale increase; 25% versus 1%, P<0.001) and acute infarct growth (>10% on MRI-diffusion-weighted imaging; 79% versus 53%, P=0.02) from baseline to 5 days were more common among those with poor outcome. Conclusions-Patients with mild ischemic stroke have substantial rates (29%) of disability at 90 days. (Stroke. 2012;43: 560-562.)
引用
收藏
页码:560 / 562
页数:3
相关论文
共 9 条
[1]   Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility [J].
Barber, PA ;
Zhang, J ;
Demchuk, AM ;
Hill, MD ;
Buchan, AM .
NEUROLOGY, 2001, 56 (08) :1015-1020
[2]   Change in Diffusion-Weighted Imaging Infarct Volume Predicts Neurologic Outcome at 90 Days Results of the Acute Stroke Accurate Prediction (ASAP) Trial Serial Imaging Substudy [J].
Barrett, Kevin M. ;
Ding, Yong Hong ;
Wagner, Douglas P. ;
Kallmes, David F. ;
Johnston, Karen C. .
STROKE, 2009, 40 (07) :2422-2427
[3]   Long-Term Functional Recovery After First Ischemic Stroke The Northern Manhattan Study [J].
Dhamoon, Mandip S. ;
Moon, Yeseon Park ;
Paik, Myunghee C. ;
Boden-Albala, Bernadette ;
Rundek, Tatjana ;
Sacco, Ralph L. ;
Elkind, Mitchell S. V. .
STROKE, 2009, 40 (08) :2805-2811
[4]   What Is a Minor Stroke? [J].
Fischer, Urs ;
Baumgartner, Adrian ;
Arnold, Marcel ;
Nedeltchev, Krassen ;
Gralla, Jan ;
De Marchis, Gian Marco ;
Kappeler, Liliane ;
Mono, Marie-Luise ;
Brekenfeld, Caspar ;
Schroth, Gerhard ;
Mattle, Heinrich P. .
STROKE, 2010, 41 (04) :661-666
[5]   Why are eligible thrombolysis candidates left untreated? [J].
Hills, Nancy K. ;
Claiborne Johnston, S. .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2006, 31 (06) :S210-S216
[6]   Strokes With Minor Symptoms An Exploratory Analysis of the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trials [J].
Khatri, Pooja ;
Kleindorfer, Dawn O. ;
Yeatts, Sharon D. ;
Saver, Jeffrey L. ;
Levine, Steven R. ;
Lyden, Patrick D. ;
Moomaw, Charles J. ;
Palesch, Yuko Y. ;
Jauch, Edward C. ;
Broderick, Joseph P. .
STROKE, 2010, 41 (11) :2581-2586
[7]   Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke - A population-based study [J].
Kleindorfer, D ;
Kissela, B ;
Schneider, A ;
Woo, D ;
Khoury, J ;
Miller, R ;
Alwell, K ;
Gebel, J ;
Szaflarski, J ;
Pancioli, A ;
Jauch, E ;
Moomaw, C ;
Shukla, R ;
Broderick, JP .
STROKE, 2004, 35 (02) :E27-E29
[8]   Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke [J].
Smith, EE ;
Abdullah, AR ;
Petkovska, I ;
Rosenthal, E ;
Koroshetz, WJ ;
Schwamm, LH .
STROKE, 2005, 36 (11) :2497-2499
[9]   Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital [J].
van den Berg, J. S. P. ;
de Jong, G. .
ACTA NEUROLOGICA SCANDINAVICA, 2009, 120 (03) :157-160